MYRUNS, a software company, completed the acquisition of a 80% stake Evolgene Genomics, a biotechnology company. Financial terms were not disclosed. "The value of these developments are of such technological and economic magnitude that they can be incorporated into very different business areas, such as electronics, energy, the pharmaceutical sector or the cosmetics sector. This is our bet for the coming years," Xabier García Roldan, MYRUNS Founder.